CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial

P Tyrer, S Cooper, H Tyrer, Paul M Salkovskis, M Crawford, J Green, G Smith, S Reid, S Dupont, D Murphy, S Byford, D L Wang, B Barrett

Research output: Contribution to journalArticlepeer-review

27 Citations (SciVal)
171 Downloads (Pure)


Background: Abnormal health anxiety, also called hypochondriasis, has been successfully treated by cognitive behaviour therapy (CBT) in patients recruited from primary care, but only one pilot trial has been carried out among those attending secondary medical clinics where health anxiety is likely to be more common and have a greater impact on services. The CHAMP study extends this work to examine both the clinical and cost effectiveness of CBT in this population. Method/Design: The study is a randomized controlled trial with two parallel arms and equal randomization of 466 eligible patients (assuming a 20% drop-out) to an active treatment group of 5-10 sessions of cognitive behaviour therapy and to a control group. The aim at baseline, after completion of all assessments but before randomization, was to give a standard simple explanation of the nature of health anxiety for all participants. Subsequently the control group was to receive whatever care might usually be available in the clinics, which is normally a combination of clinical assessment, appropriate tests and reassurance. Those allocated to the active treatment group were planned to receive between 5 and 10 sessions of an adapted form of cognitive behaviour therapy based on the Salkovskis/Warwick model, in which a set of treatment strategies are chosen aimed at helping patients understand the factors that drive and maintain health anxiety. The therapy was planned to be given by graduate research workers, nurses or other health professionals trained for this intervention whom would also have their competence assessed independently during the course of treatment. The primary outcome is reduction in health anxiety symptoms after one year and the main secondary outcome is the cost of care after two years. Discussion: This represents the first trial of adapted cognitive behaviour therapy in health anxiety that is large enough to test not only the clinical benefits of treatment but also whether the cost of treatment is offset by savings from reduced use of other health services in comparison to the control group. Cognitive behaviour therapy for Health Anxiety in Medical Patients (CHAMP)
Original languageEnglish
Article number99
JournalBMC Psychiatry
Publication statusPublished - 14 Jun 2011


Dive into the research topics of 'CHAMP: Cognitive behaviour therapy for health anxiety in medical patients, a randomised controlled trial'. Together they form a unique fingerprint.

Cite this